FDA clears 14-day version of cardiac patch monitorNovember 15, 2019
The USFDA has granted clearance to the 14-day version of the Carnation Ambulatory Monitor (CAM), the industry’s only P-wave centric ambulatory cardiac patch monitor and arrhythmia detection device.
Developed to provide clinicians greater flexibility in cardiac monitoring over a longer period, the CAM patch will now be offered in a 14-day extended wear version that utilizes the same innovative P-wave focused technology that powers the existing 2-day and 7-day CAM product lines.
The CAM patch’s breakthrough technology reliably detects and records the P-wave, a small amplitude signal of the ECG originating in the atrium that is essential to accurate arrhythmia diagnosis and patient management.
The new 14-day CAM patch enables up to double the duration of P-wave optimized detection and monitoring over the current 7-day CAM patch, potentially discovering additional, less-frequent arrhythmias.